A detailed history of State Of Wisconsin Investment Board transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 98,391 shares of HALO stock, worth $5.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,391
Previous 113,935 13.64%
Holding current value
$5.05 Million
Previous $4.21 Million 4.96%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$33.68 - $41.95 $523,521 - $652,070
-15,544 Reduced 13.64%
98,391 $4 Million
Q4 2023

Feb 12, 2024

BUY
$33.32 - $42.1 $26,189 - $33,090
786 Added 0.69%
113,935 $4.21 Million
Q3 2023

Nov 14, 2023

SELL
$36.46 - $44.03 $156,267 - $188,712
-4,286 Reduced 3.65%
113,149 $4.32 Million
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $191,702 - $245,262
-6,331 Reduced 5.12%
117,435 $4.24 Million
Q1 2023

May 15, 2023

SELL
$32.86 - $55.7 $470,292 - $797,178
-14,312 Reduced 10.37%
123,766 $4.73 Million
Q4 2022

Feb 14, 2023

SELL
$40.06 - $59.44 $109,524 - $162,508
-2,734 Reduced 1.94%
138,078 $7.86 Million
Q3 2022

Nov 14, 2022

SELL
$38.53 - $51.78 $171,227 - $230,110
-4,444 Reduced 3.06%
140,812 $5.57 Million
Q2 2022

Aug 15, 2022

SELL
$37.35 - $48.3 $1.62 Million - $2.1 Million
-43,444 Reduced 23.02%
145,256 $6.39 Million
Q4 2021

Feb 11, 2022

BUY
$31.82 - $40.75 $44,548 - $57,050
1,400 Added 0.75%
188,700 $7.59 Million
Q2 2021

Aug 12, 2021

BUY
$38.84 - $51.31 $66,028 - $87,227
1,700 Added 0.92%
187,300 $8.51 Million
Q1 2021

May 17, 2021

SELL
$39.51 - $51.45 $485,973 - $632,835
-12,300 Reduced 6.22%
185,600 $7.74 Million
Q4 2020

Feb 03, 2021

SELL
$25.81 - $43.62 $836,244 - $1.41 Million
-32,400 Reduced 14.07%
197,900 $8.45 Million
Q3 2020

Nov 16, 2020

BUY
$25.74 - $29.63 $319,176 - $367,412
12,400 Added 5.69%
230,300 $6.05 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $165,750 - $273,462
10,200 Added 4.91%
217,900 $5.84 Million
Q1 2020

May 06, 2020

SELL
$13.9 - $21.83 $88,960 - $139,712
-6,400 Reduced 2.99%
207,700 $3.74 Million
Q3 2019

Nov 12, 2019

BUY
$15.2 - $17.69 $498,560 - $580,232
32,800 Added 18.09%
214,100 $3.32 Million
Q2 2019

Aug 14, 2019

BUY
$14.75 - $17.26 $122,425 - $143,258
8,300 Added 4.8%
181,300 $3.12 Million
Q1 2019

May 13, 2019

BUY
$13.94 - $17.58 $620,330 - $782,309
44,500 Added 34.63%
173,000 $2.79 Million
Q4 2018

Feb 11, 2019

BUY
$13.33 - $18.66 $18,662 - $26,124
1,400 Added 1.1%
128,500 $1.88 Million
Q2 2018

Aug 03, 2018

BUY
$16.87 - $20.3 $155,204 - $186,760
9,200 Added 7.8%
127,100 $2.14 Million
Q4 2017

Feb 08, 2018

BUY
$16.75 - $20.8 $634,825 - $788,320
37,900 Added 47.38%
117,900 $2.39 Million
Q3 2017

Nov 01, 2017

BUY
$11.76 - $17.4 $940,800 - $1.39 Million
80,000
80,000 $1.39 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.15B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.